Effect of metocarbamol on pain

The study of effect of metocarbamol on postoperative pain after cholecystectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201101124505N2

Enrollment

Registered

2011-02-07

Start date

2011-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Acute pain

Interventions

Intervention 1: Intervention group: Metocarbamol 500mg, IV slowly, diluted in 5 cc normal saline. Intervention 2: Control group: normal saline, 10 cc, IV slowly.

Treatment - Drugs

Intervention group: Metocarbamol 500mg, IV slowly, diluted in 5 cc normal saline

Control group: normal saline, 10 cc, IV slowly

Eligibility

Sex/Gender

All

Age

30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASA class 1-2, age between 30-50 years old, weight lower than 100kg, undergoing general anesthesia for cholecystectomy elective surgery Exclusion criteria: presence of systemic illness such as lung, kidney, or heart diseases, smoking, presence of side effects to the study drug, incidence of side effect such as lung and heart reactions, consumption of other drugs affecting pain

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 1, 3, 6, 12 hours. Method of measurement: VAS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasol Kavyannejad

Hamedan University of Medical Sciences and Health Services

rasol.kavian@umsha.ac.ir+98 918 969 9149

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026